The main focus of my research program is the quality of care received by patients with cancer especially in regards to delivery of systemic therapy. I am also interested in understanding the evolution and dissemination of findings from randomized controlled trials in cancer.
Curr Oncol. 2017 Aug;24(4):e277-e284
Support Care Cancer. 2017 Jul 25;:
Expanding the Spectrum of Colonic Manifestations in Tuberous Sclerosis: L-Cell Neuroendocrine Tumor Arising in the Background of Rectal PEComa.
Endocr Pathol. 2017 Jul 21;:
My Team of Care Study: A Pilot Randomized Controlled Trial of a Web-Based Communication Tool for Collaborative Care in Patients With Advanced Cancer.
J Med Internet Res. 2017 Jul 18;19(7):e219
Endocr Pathol. 2017 Jul 17;:
Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative Data.
J Clin Oncol. 2017 Jul 06;:JCO2016707950
Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer.
Cancer. 2017 Jul 05;:
JAMA Oncol. 2017 Jun 01;:
Curr Oncol. 2017 Apr;24(2):95-102
A population-based assessment of primary care visits during adjuvant chemotherapy for breast cancer.
Curr Oncol. 2017 Apr;24(2):90-94
Medical Oncologist, Princess Margaret Cancer Centre
Associate Professor of Medicine, University of Toronto
Clinical Lead, Quality Care and Access, Systemic Treatment Program, Cancer Care Ontario
Adjuct Scientist, Institute for Clinical Evaluative Sciences